đ¸ PCOS in Indian Women: The Facts & The Myth
- Team Quikphyt

- Oct 7
- 6 min read
âPCOS is not your faultâbut with the right plan, it can be managed powerfully.â
Why it Matters (Especially in India)
Recent Indian data suggest 7â20%Â of women meet diagnostic criteria for PCOS (wide range due to different criteria), with college-going women in Delhi-NCR ~17%âthatâs 1 in 6. (JAMA Network)
South Asians develop insulin resistance and diabetes at lower BMI; the cardiometabolic risk arrives earlier and at leaner weights than in many other populations. (PMC)
For Asian Indians, overweight begins at BMI âĽ23 and obesity at âĽ25, so ânormal BMIâ by Western charts may still be risky for us. (PMC)
What PCOS is (and is Not)
Diagnostic Criteria (Adults)
PCOS is a clinical syndrome diagnosed when any 2 of 3 are present after excluding mimics:
Ovulatory dysfunction (infrequent/absent periods)
Clinical/biochemical hyperandrogenism (hirsutism, acne; elevated androgens)
Polycystic ovarian morphology (PCOM) or elevated AMH (per 2023 update)(Exclude thyroid disease, hyperprolactinemia, non-classic CAH, Cushingâs, and androgen-secreting tumors.) (PMC)
Important 2023 Updates
Adolescents: Do NOT use ultrasound/AMH for diagnosis; require both persistent cycle irregularity (relative to years since menarche) and hyperandrogenism. Many teens show âPCOM-likeâ ovaries normally; label as âat riskâ and follow up. (MDPI)
Ultrasound thresholds (adults): modern transvaginal US suggests âĽ20 follicles/ovary or ovarian volume âĽ10 mL as PCOM. (Older 12-follicle cut offs over diagnose.) (MDPI)
How Common is PCOS in India?
Meta-analysis (India):Â Pooled prevalence ~11.3%Â with Rotterdam criteria. (PMC)
National/Regional snapshots:Â 7.2% (NIH criteria)Â vs ~19.6% (Rotterdam)Â across multiple Indian cohorts; Delhi-NCR student cohort 17.4%Â (2024). (JAMA Network)
Why weâre at higher risk: South Asian women with PCOS tend to have higher insulin levels and lower insulin sensitivity compared with Caucasian womenâraising long-term risks of type 2 diabetes and CVD. (PMC)
Comprehensive PCOS Screening (The QuikPhyt Baseline)
At Diagnosis (Adults & Teens):
Glucose: Prefer 75-g OGTT (fasting + 2-hour), as it detects problems missed by fasting glucose/HbA1c; recheck every 1â3 years based on risk. (OUP Academic)
Lipids, BP, BMI & Waist:Â at baseline; use Asian Indian BMI cut-offs. (Monash University)
Mental health: Screen for depression/anxiety using validated tools (PHQ-9/GAD-7). (Monash University)
Sleep & Liver: Screen for sleep apnea risk (snoring, daytime sleepiness) and check ALT; PCOS carries higher metabolic and sleep disorder burden. (Monash University)
Gynaecologic: If >90 days without periods, induce withdrawal bleed (to protect the endometrium) and evaluate per guidelines. (PMC)
Lifestyle is First-Line (and Powerful)
Exercise (Minimum Effective Dose, then Build)
Aim for 150â300 min/week moderate or 75â150 min/week vigorous aerobic activity plus 2â3 days/week strength training; this improves insulin resistance and ovulation. (ScienceDirect)
HIIT can match or outperform standard cardio for insulin sensitivity, VOâmax, menstrual cyclicity in PCOSâuse if you enjoy it and can recover well. (PubMed)
Meal-time walks (10â15 min)Â blunt post-meal glucose spikes; add NEATÂ (steps, stairs, chores).
Nutrition (Indian Plate, Low GI Emphasis)
Evidence favours low-GI / high-fibre patterns for insulin sensitivity; think millets (ragi, bajra), legumes (dal/chana/rajma), whole dals/veg, nuts, seeds; minimize Maida, Sugar-Sweetened Beverages, Ultra-Processed Snacks. (PMC)
Protein with each meal (veg or non-veg) supports satiety, muscle, glucose control; vegetarians: dal + dahi/paneer + soy/tofu + nuts/seeds.
Weight change target: even 5â7% loss improves cycles/metabolic health; but benefit occurs even without weight loss when fitness and diet quality improve. (ScienceDirect)
S
tress, Sleep, Circadian Hygiene
Mind-body (yoga, meditation, breathwork) improves HRV/stress axis; 7â9 hours regular sleep improves insulin action; screen for OSA if snoring/daytime sleepiness. (Monash University)
Evidence-Based Medical Therapy (Personalized)
For Irregular Cycles, Acne, Hirsutism (not seeking Pregnancy):
COCP (combined oral contraceptive pill) is first-line to regulate cycles and lower androgens. Use lowest effective ethinyl estradiol dose; reassess periodically. (cosrh.org)
If hirsutism persists after ~6 months: add antiandrogen (e.g., spironolactone). Must use reliable contraception due to teratogenic risk. Consider laser/photoepilation ¹ topical eflornithine for facial hair. (OUP Academic)
For Metabolic Features (IR, Pre-Diabetes, Higher BMI):
Metformin improves insulin sensitivity, weight trajectory, and cycle regularity; particularly useful in overweight/obese or high-risk ethnic groups. Monitor B12 with long-term use. (Lifestyle remains foundational.) (eshre.eu)
Fertility (Seeking Pregnancy):
Letrozole is first-line ovulation induction in PCOS (superior to clomiphene for live birth in most studies). Escalate per protocol; consider gonadotropins/IVF if resistant. (OUP Academic)
âALWAYS TAKE YOUR DOCTOR'S OR PHYSICIAN'S ADVICE BEFORE ANY LIFESTYLE CHANGES AND/OR MEDICATION.â
Supplements: whatâs Solid, whatâs Optional
Inositols (myo-/D-chiro; often 40:1): evidence is mixed; some RCTs/meta-analyses show metabolic/reproductive benefits, others find inconclusive effects. Consider only as an adjunct, after discussing uncertainty and cost. (PubMed)
Vitamin D:Â deficiency is common; treat deficiency, but itâs not a primary PCOS therapy. Some RCTs show metabolic benefits when deficient. (PubMed)
Omega-3 (EPA/DHA): meta-analyses suggest improvements in triglycerides, HOMA-IR; best over âĽ8 weeks. Helpful if hypertriglyceridemia or low fish intake. (PMC)
Bottom line: Lifestyle + guideline-directed meds are core. Supplements are optional adjuncts, targeted to deficiencies or specific metabolic goals.
PCOS across life stages (India-specific pearls)
Adolescents: Diagnose carefully (avoid over-labelling). Treat symptoms; focus on habits, skin, and cycle regulation. Avoid ultrasound/AMH for diagnosis in the first 8 years post-menarche. (MDPI)
Preconception: Optimize weight/fitness, correct iron, vitamin D, B12, and aim for stable cycles; discuss letrozole as first-line if anovulatory. (OUP Academic)
Pregnancy: PCOS is high-risk (GDM, hypertensive disorders). Early OGTT and close monitoring advised. (Monash University)
Long-term: Recheck glucose (OGTT) and lipids every 1â3 years; maintain strength + cardio as ânon-negotiables.â (OUP Academic)

The QuikPhyt 12-Week PCOS Action Plan (implementable)
Weeks 1â2: Baseline & Reset
Labs: OGTT, lipids, ALT, TSH, prolactin, androgens; PHQ-9/GAD-7; OSA screen. Start 150 min/week cardio + 2 strength days; 10-min walk after meals.
Weeks 3â6: Build Consistency
Progress to 200â250 min/week cardio or HIIT 2x/wk if tolerated; progressive strength (lower-upper-full body split).
Plate: ½ veg, Âź dal/beans/lean protein, Âź whole grains/millets; 30â40 g protein/meal.
Weeks 7â12: Personalize & Measure
If irregular cycles/hirsutism: consider COCP; reassess at 3 months.
If IR/prediabetes or BMI âĽ23 with central adiposity: add metformin.
If trying to conceive: plan letrozole cycle after lifestyle phase-in.
Track: waist, cycles, energy, acne/hair, strength/VOâ. Re-check fasting lipids/glucose as advised.
(Our coaches at QuikPhyt Health Hub & Gym can deliver a hyper-individualised plan matching time, goals, and medical profile.)
Myth vs Fact (Shareable)
âPCOS = always Obese.â â Many Indian women with PCOS are not obese yet still insulin-resistant. âď¸ (PMC)
âUltrasound is mandatory to diagnose.â â Not if you already have irregular cycles + hyperandrogenism (adults). âď¸ (Monash University)
âTeen acne + irregular periods = PCOS.â â Adolescents need both, persistent irregular cycles and hyperandrogenism; no US/AMH early after menarche. âď¸ (MDPI)
âHIIT is dangerous for PCOS.â â Appropriately progressed HIIT can improve insulin sensitivity and cycles. âď¸ (PubMed)
Key References (High-Quality)
International PCOS Guideline (2023 update)Â â assessment, screening, and management recommendations. (OUP Academic)
Monash/ESHRE/ASRM PDF summaries â detailed criteria, lifestyle chapter, OGTT preference. (Monash University)
India-specific prevalence â JAMA Network Open (2024); Indian meta-analysis (2022); Delhi-NCR cohort (2024). (JAMA Network)
South Asian metabolic risk â comparative studies on insulin resistance. (PMC)
Exercise & PCOSÂ â 2024 review and RCTs (HIIT vs moderate). (ScienceDirect)
Low-GI nutrition â systematic review/meta-analysis. (PMC)
Hirsutism management â Endocrine Society guidance & 2023 meta-analysis (antiandrogens). (OUP Academic)
Supplements evidence â Inositol (inconclusive 2024), omega-3 meta-analyses, vitamin D in deficiency. (PubMed)
Asian Indian BMI cut-offs â Indian consensus review. (PMC)
The Takeaway
PCOS is manageableâand often dramatically soâwhen you combine(1) lifestyle, (2) guideline-based medication, and (3) regular monitoring. In the Indian context, adjusting for lower BMI cut-offs, low-GI traditional foods, and high cardiometabolic risk makes all the difference.
âALWAYS TAKE YOUR DOCTOR'S OR PHYSICIAN'S ADVICE BEFORE ANY LIFESTYLE CHANGES AND/OR MEDICATION.â



Comments